Search

Hengmiao M Cheng

age ~60

from San Diego, CA

Get Report
Also known as:
  • Miao Cheng Hengmiao
  • Lucy Cheng
  • Miao Cheng Heng
  • O Cheng
Phone and address:
16213 Cayenne Ridge Rd, San Diego, CA 92127
(858)6760969
Related to:
Connected to:

Hengmiao Cheng Phones & Addresses

  • 16213 Cayenne Ridge Rd, San Diego, CA 92127 • (858)6760969 • (858)6763969
  • 12610 Torrey Bluff Dr, San Diego, CA 92130 • (858)2591478
  • Fremont, CA
  • Lathrop, CA
  • Poway, CA
  • Rancho Santa Fe, CA
  • Lodi, CA
  • East Lyme, CT
  • Somerville, MA
  • Cambridge, MA
  • 16213 Cayenne Ridge Rd, San Diego, CA 92127

Work

  • Company:
    Erasca
    Sep 2020
  • Position:
    Senior director, medicinal chemistry

Education

  • School / High School:
    Harvard University

Skills

Drug Design • Oncology • Organic Synthesis • Lead Optimization • Medicinal Chemistry • Chemistry • Drug Discovery • Synthetic Chemistry • Organic Chemistry • Drug Development • Life Sciences • Biotechnology • Pharmaceutical Industry

Industries

Pharmaceuticals

Resumes

Hengmiao Cheng Photo 1

Senior Director, Medicinal Chemistry

view source
Location:
400 Crossing Blvd, Bridgewater, NJ 08807
Industry:
Pharmaceuticals
Work:
Erasca
Senior Director, Medicinal Chemistry
Pfizer
Associate Research Fellow
Education:
Harvard University
University of Toronto
University of Alberta
Doctorates, Doctor of Philosophy, Organic Chemistry Xiamen University
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Design
Oncology
Organic Synthesis
Lead Optimization
Medicinal Chemistry
Chemistry
Drug Discovery
Synthetic Chemistry
Organic Chemistry
Drug Development
Life Sciences
Biotechnology
Pharmaceutical Industry

Us Patents

  • Tricyclic Compounds, Compositions, And Methods

    view source
  • US Patent:
    7547714, Jun 16, 2009
  • Filed:
    Jan 31, 2008
  • Appl. No.:
    12/023323
  • Inventors:
    Hengmiao (Henry) Cheng - San Diego CA, US
  • Assignee:
    Pfizer, Inc. - New York NY
  • International Classification:
    A61K 31/44
    C07D 213/72
  • US Classification:
    514352, 546285
  • Abstract:
    The present invention is directed to compounds of Formula I:.

  • Tricyclic Compound, Compositions, And Methods

    view source
  • US Patent:
    7598231, Oct 6, 2009
  • Filed:
    Jan 31, 2008
  • Appl. No.:
    12/023362
  • Inventors:
    Hengmiao (Henry) Cheng - San Diego CA, US
    Rajesh Devraj - Chesterfield MO, US
    Gary A DeCresenzo - St. Charles MO, US
    Xiao Hu - Ballwin MO, US
    Kevin D. Jerome - St. Charles MO, US
    Mark Obukowicz - Kirkwood MO, US
    Lisa Olson - Hopkinton MA, US
    Paul V. Rucker - Carlsbad CA, US
    Ronald Keith Webber - St. Peters MO, US
  • Assignee:
    Pfizer, Inc. - New York NY
  • International Classification:
    A61K 31/675
    C07F 9/58
  • US Classification:
    514 89, 546 22, 514352
  • Abstract:
    The present invention is directed to compounds of Formula I:.

  • 4-Methylpyridopyrimidinone Compounds

    view source
  • US Patent:
    7696213, Apr 13, 2010
  • Filed:
    Sep 13, 2007
  • Appl. No.:
    11/854999
  • Inventors:
    Hengmiao Cheng - San Diego CA, US
    Dilip Bhumralkar - Valencia CA, US
    Klaus Ruprecht Dress - San Diego CA, US
    Jacqui Elizabeth Hoffman - San Diego CA, US
    Mary Catherine Johnson - San Diego CA, US
    Robert Steven Kania - San Diego CA, US
    Phuong Thi Quy Le - San Diego CA, US
    Mitchell David Nambu - San Diego CA, US
    Mason Alan Pairish - San Diego CA, US
    Michael Bruno Plewe - San Diego CA, US
    Khanh Tuan Tran - San Diego CA, US
  • Assignee:
    Pfizer Inc - New York NY
  • International Classification:
    C07D 471/04
    C07D 487/04
    A61K 31/519
    A61P 35/00
  • US Classification:
    51426411, 544279
  • Abstract:
    The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I),.

  • Triazolopyrazine Derivatives

    view source
  • US Patent:
    7732604, Jun 8, 2010
  • Filed:
    May 8, 2007
  • Appl. No.:
    11/745921
  • Inventors:
    Hengmiao Cheng - San Diego CA, US
    Jingrong Jean Cui - San Diego CA, US
    Jacqui Elizabeth Hoffman - San Diego CA, US
    Lei Jia - San Diego CA, US
    Mary Catherine Johnson - San Diego CA, US
    Robert Steven Kania - San Diego CA, US
    Phuong Thi Quy Le - San Diego CA, US
    Mitchell David Nambu - San Diego CA, US
    Mason Alan Pairish - San Diego CA, US
    Hong Shen - San Diego CA, US
  • Assignee:
    Pfizer Inc. - New York NY
  • International Classification:
    C07D 471/00
    C07D 487/00
    C07D 491/00
    C07D 495/00
    C07D 497/00
  • US Classification:
    544350
  • Abstract:
    The invention relates to compounds of the formula I.

  • Tricyclic Compounds, Compositions And Methods

    view source
  • US Patent:
    7786097, Aug 31, 2010
  • Filed:
    Jul 21, 2009
  • Appl. No.:
    12/506825
  • Inventors:
    Hengmiao (Henry) Cheng - San Diego CA, US
    Rajesh Devraj - Chesterfield MO, US
    Gary A Decresenzo - St. Charles MO, US
    Xiao Hu - St. Charles MO, US
    Kevin D. Jerome - St. Charles MO, US
    Mark Obukowicz - Kirkwood MO, US
    Lisa Olson - Hopkinton MA, US
    Paul V. Rucker - Carlsbad CA, US
    Ronald Keith Webber - St. Peters MO, US
  • Assignee:
    Pfizer Inc. - New York NY
  • International Classification:
    A61K 31/675
    A61K 31/44
  • US Classification:
    514 89, 514352, 514886
  • Abstract:
    The present invention is directed to compounds of Formula I:.

  • Tricyclic Compounds, Compositions And Methods

    view source
  • US Patent:
    8158660, Apr 17, 2012
  • Filed:
    May 8, 2009
  • Appl. No.:
    12/437704
  • Inventors:
    Hengmiao Cheng - San Diego CA, US
    Xiao Hu - Ballwin MO, US
    Kevin D. Jerome - St. Charles MO, US
    Mark G. Obukowicz - Kirkwood MO, US
    Lisa Maria Olson - Hopkinton MA, US
    Paul V. Rucker - Carlsbad CA, US
    Ronald Keith Webber - St. Peters MO, US
  • Assignee:
    Pfizer Inc. - New York NY
  • International Classification:
    A61K 31/44
  • US Classification:
    514352, 530409
  • Abstract:
    The present invention is directed to compounds of Formula I:.

  • 4-Methylpyridopyrimidinone Compounds

    view source
  • US Patent:
    8273755, Sep 25, 2012
  • Filed:
    Feb 9, 2010
  • Appl. No.:
    12/702937
  • Inventors:
    Hengmiao Cheng - San Diego CA, US
    Dilip Bhumralkar - Valencia CA, US
    Klaus Ruprecht Dress - San Diego CA, US
    Jacqui Elizabeth Hoffman - San Diego CA, US
    Mary Catherine Johnson - San Diego CA, US
    Robert Steven Kania - San Diego CA, US
    Phuong Thi Quy Le - San Diego CA, US
    Mitchell David Nambu - San Diego CA, US
    Mason Alan Pairish - San Diego CA, US
    Michael Bruno Plewe - San Diego CA, US
    Khanh Tuan Tran - San Diego CA, US
  • Assignee:
    Pfizer Inc - New York NY
  • International Classification:
    C07D 471/04
    A61K 31/519
    A61P 35/00
  • US Classification:
    51426411, 544279
  • Abstract:
    The present invention is directed to novel 4-methylpyridopyrimidinone compounds of Formula (I),.

  • Tricyclic Compounds, Compositions, And Methods

    view source
  • US Patent:
    8445520, May 21, 2013
  • Filed:
    Dec 21, 2011
  • Appl. No.:
    13/333104
  • Inventors:
    Hengmiao Cheng - San Diego CA, US
    Xiao Hu - Ballwin MO, US
    Kevin D. Jerome - St. Charles MO, US
    Mark G. Obukowicz - Kirkwood MO, US
    Lisa Maria Olson - Hopkinton MA, US
    Paul V. Rucker - Carlsbad CA, US
    Ronald Keith Webber - St. Peters MO, US
  • Assignee:
    Pfizer Inc. - New York NY
  • International Classification:
    A61K 31/44
    C07D 211/68
    C12N 5/00
  • US Classification:
    514352, 546265, 435375
  • Abstract:
    The present invention is directed to compounds of Formula I:.
Get Report for Hengmiao M Cheng from San Diego, CA, age ~60
Control profile